Table: Sapporo Clinical Lab - 6-MTH group results

Sapporo Clinical Laboratory

08/11/2021 06:30

Nov 8 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2021        Sep 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             9.57                8.36             17.41    
                 (+14.4 pct)         (-5.4 pct)       (-0.5 pct)  
  Operating        777 mln             368 mln          855 mln   
                (+110.9 pct)         (-25.2 pct)      (-25.1 pct) 
  Recurring        820 mln             376 mln          957 mln   
                (+118.1 pct)         (-25.9 pct)      (-19.4 pct) 
  Net              457 mln             225 mln          574 mln   
                (+103.1 pct)         (-30.8 pct)      (-27.7 pct) 
  EPS            134.13 yen           65.88 yen       167.73 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T